Natixis Advisors LLC Has $118.32 Million Position in McKesson Co. (NYSE:MCK)

Natixis Advisors LLC lifted its position in McKesson Co. (NYSE:MCK - Free Report) by 14.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 207,617 shares of the company's stock after buying an additional 26,515 shares during the period. Natixis Advisors LLC owned about 0.16% of McKesson worth $118,323,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in the business. MidAtlantic Capital Management Inc. acquired a new stake in shares of McKesson during the third quarter worth about $29,000. RPg Family Wealth Advisory LLC bought a new position in McKesson in the third quarter valued at approximately $31,000. Synergy Asset Management LLC acquired a new position in shares of McKesson in the fourth quarter valued at approximately $32,000. Crews Bank & Trust bought a new stake in shares of McKesson during the fourth quarter worth $33,000. Finally, Atala Financial Inc acquired a new stake in shares of McKesson during the fourth quarter worth $34,000. Institutional investors and hedge funds own 85.07% of the company's stock.

McKesson Price Performance

Shares of NYSE MCK traded up $2.48 during mid-day trading on Wednesday, hitting $664.09. 961,980 shares of the stock traded hands, compared to its average volume of 791,554. McKesson Co. has a twelve month low of $464.42 and a twelve month high of $672.68. The firm has a 50 day simple moving average of $611.56 and a two-hundred day simple moving average of $572.36. The company has a market cap of $83.23 billion, a PE ratio of 30.41, a price-to-earnings-growth ratio of 1.29 and a beta of 0.52.

Remove Ads

McKesson (NYSE:MCK - Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The company reported $8.03 earnings per share for the quarter, missing the consensus estimate of $8.60 by ($0.57). McKesson had a negative return on equity of 181.26% and a net margin of 0.82%. On average, equities research analysts anticipate that McKesson Co. will post 32.77 earnings per share for the current fiscal year.

McKesson Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, April 1st. Stockholders of record on Monday, March 3rd will be paid a dividend of $0.71 per share. This represents a $2.84 annualized dividend and a dividend yield of 0.43%. The ex-dividend date is Monday, March 3rd. McKesson's payout ratio is currently 13.00%.

Insider Transactions at McKesson

In other McKesson news, EVP Leann B. Smith sold 579 shares of McKesson stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $572.79, for a total transaction of $331,645.41. Following the transaction, the executive vice president now directly owns 864 shares of the company's stock, valued at approximately $494,890.56. The trade was a 40.12 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Brian S. Tyler sold 8,961 shares of the stock in a transaction dated Friday, February 21st. The shares were sold at an average price of $597.99, for a total value of $5,358,588.39. Following the completion of the sale, the chief executive officer now directly owns 60,664 shares of the company's stock, valued at approximately $36,276,465.36. The trade was a 12.87 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 18,689 shares of company stock worth $11,187,351. Company insiders own 0.11% of the company's stock.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on MCK. Evercore ISI lifted their price objective on shares of McKesson from $650.00 to $675.00 and gave the company an "outperform" rating in a research report on Thursday, February 6th. StockNews.com cut McKesson from a "strong-buy" rating to a "buy" rating in a research note on Friday, February 14th. Morgan Stanley raised their price target on McKesson from $612.00 to $642.00 and gave the stock an "overweight" rating in a research report on Tuesday, December 17th. Mizuho initiated coverage on McKesson in a research note on Wednesday, December 4th. They issued a "neutral" rating and a $630.00 price target for the company. Finally, Citigroup decreased their target price on shares of McKesson from $713.00 to $677.00 and set a "buy" rating on the stock in a report on Friday, January 10th. Two analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $649.36.

McKesson Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.